HLB bioStep Co.,Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 278650.KQ | TECH | 1548.HK | BIOCON.NS | 301080.SZ | BIOA-B.ST | |
|---|---|---|---|---|---|---|
| Market cap | 103.40B | 11.39B | 78.27B | 548.65B | 15.95B | 26.73B |
| P/E (TTM) | — | 62.6 | — | 99.1 | 88.1 | 255.3 |
| Forward P/E | — | 31.4 | 87.5 | 30.6 | — | 103.9 |
| Price/book | — | 5.4 | 2.5 | 1.6 | 6.0 | 13.3 |
| Dividend yield | — | 0.44% | — | 0.15% | 0.62% | 0.67% |
| 1-year change | −10.46% | +13.78% | +106.04% | −7.13% | +61.69% | +2.74% |
| Today | +0.33% | +0.08% | +2.69% | −1.47% | −2.40% | +0.40% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 278650.KQ news ›HLB BioStep to Carry Out KRW 5 Billion National Project on Animal Alternative Testing Methods
Published 13 Oct.2026 10:22(KST) HLB BioStep is carrying out a national project on New Approach Methodologies (NAMs) commissioned by the Ministry of Trade, Industry and Energy. HLB BioStep will verify whether immunogenicity prediction…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
asiae.co.kr1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.